Benzinga’s Top Pre-Market Losers (CNX, BSX, ISPH, CYTX)
March 15, 2010 8:32 AM
CONSOL Energy Inc. (NYSE: CNX) decreased 5.76% to $51.20 in the pre-market session. Dominion (NYSE: D) announced that it has agreed to sell its natural gas and oil exploration and production business to a newly-formed subsidiary of CONSOL Energy, for a total of $3.475 billion. The 52-week trading range for CNX is $24.01 - $58.00. CONSOL Energy has gained over 25% in the last six months.
Boston Scientific Corporation (NYSE: BSX) tumbled 20.44% to $6.20 in the pre-market session. Boston Scientific Corp. announced that it has reached the milestone of 1000 European patients using its LATITUDE Patient Management System. The 52-week trading range for BSX is $7.16 - $11.77. BSX has declined over 31% in the last six months.
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) plunged 12.18% to $6.20 in the pre-market session. Inspire Pharmaceuticals, Inc. announced results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis. ISPH closed at $7.06 in the previous trading session. ISPH has climbed over 98% in the last year.
Cytori Therapeutics Inc. (USA) (NASDAQ: CYTX) plunged 4.98% to $5.72 in the pre-market session. CYTX closed at $6.02 in the last trading session. In the last six months, Cytori Therapeutics has surged over 59%. The 52-week trading range for CYTX is $1.42 - $9.50.
